Forskning ved Københavns Universitet - Københavns Universitet


Design, synthesis, and pharmacological characterization of novel, potent NMDA receptor antagonists

Publikation: Forskning - peer reviewTidsskriftartikel

Paola Conti, Marco De Amici, Giovanni Grazioso, Gabriella Roda, Federico F Barberis Negra, Birgitte Nielsen, Tine B Stensbøl, Ulf Madsen, Hans Bräuner-Osborne, Karla Andrea Frydenvang, Giovambattista De Sarro, Lucio Toma, Carlo De Micheli

The two diastereomeric pairs of acidic amino acids 5-(2-amino-2-carboxyethyl)-4,5-dihydroisoxazole-3-carboxylic acid (8A/8B) and 4-(2-amino-2-carboxyethyl)-5,5-dimethyl-4,5-dihydroisoxazole-3-carboxylic acid (10A/10B) were prepared via a strategy based on a 1,3-dipolar cycloaddition. The four amino acids were tested at ionotropic and metabotropic glutamate receptors. None of the compounds was active, neither as agonists nor as antagonists, at 1 mM on metabotropic receptors (mGluR1, -2, -4, and -5 expressed in CHO cell lines). Conversely, the pair of stereoisomers 8A/8B showed a remarkable affinity, antagonist potency, and selectivity for NMDA receptors, when tested on ionotropic glutamate receptors. The affinity of 8A proved to be 5 times higher than that of diastereomer 8B (K(i) values 0.21 and 0.96 microM, respectively). Furthermore, compounds 8A and 8B exhibited a noteworthy anticonvulsant activity in in vivo tests on DBA/2 mice. Derivative 10A was inactive at all ionotropic glutamate receptors, whereas its stereoisomer 10B displayed a seizable binding to both NMDA and AMPA receptors.
TidsskriftJournal of Medicinal Chemistry
Sider (fra-til)6740-8
Antal sider9
StatusUdgivet - 30 dec. 2004

ID: 44758111